Medical device companies face years-long delays between FDA approval and Medicare coverage decisions

Medical device manufacturers experience extended periods of 'coverage purgatory' where their FDA-approved devices cannot generate revenue because Medicare hasn't yet determined coverage eligibility. This creates cash flow crises, delayed market entry, and competitive disadvantages, as companies cannot bill patients or insurers while awaiting CMS coverage decisions that can take years despite FDA clearance.